Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 114,200 shares, an increase of 275.7% from the November 30th total of 30,400 shares. Based on an average daily volume of 1,420,000 shares, the short-interest ratio is currently 0.1 days. Approximately 27.0% of the company’s stock are short sold.

Avalon GloboCare Stock Down 7.1 %

Shares of Avalon GloboCare stock traded down $0.29 on Thursday, hitting $3.81. 18,138 shares of the company’s stock traded hands, compared to its average volume of 498,755. The firm’s 50-day moving average is $3.24 and its 200 day moving average is $4.45. The stock has a market cap of $4.17 million, a P/E ratio of -0.19 and a beta of 0.27. Avalon GloboCare has a 52-week low of $2.11 and a 52-week high of $21.60.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.